Since the late 1990s, with the emergence of regenerative medicine, third-generation biomaterials possessing inductive regenerative properties have become a current research hotspot. These materials can endogenously induce cell division to achieve tissue regeneration. Third-generation biomaterials can be applied in skin defect repair, soft tissue repair, articular cartilage repair, vascular and catheter coatings, and medical aesthetics, demonstrating significant development potential.
As an innovative R&D company specializing in bio-regenerative materials, Baiyiyuan Biology has been engaged in the research and strategic development of third-generation biomaterials since its inception. These materials are designed with endogenous induction capabilities to promote regenerative repair and achieve true tissue regeneration. Through years of technological accumulation, the company has established exceptionally high standards in manufacturing processes and technical specifications. Its SIS-ECM technology possesses strong platform characteristics, with products suitable for the regenerative repair of all human soft tissues, covering applications across the full spectrum of surgical disciplines.
On Monday, October 23, at 19:30, the 33rd session of VCBeat Select New Product Appreciation invitesShen Chenye, Chief Operating Officer of Baiyiyuan Biotech; Ma Li, Implant Director of Meiwei Dental Medical Group, bringing Baiyiyuan Shengwu's Baijianggu®Introduction to Absorbable Biological Membranes.

· Multi-layered, naturally dense structure for superior barrier efficacy and enhanced bone augmentation.
· Durable Barrier, Establishing a Stable Environment for Bone Regeneration.
· Reversible design for a superior user experience.
· Rapid vascularization and predictable augmentation of hard and soft tissues.
· No distinction between front and back, making operation simpler;
· Superior mechanical properties, enhanced plasticity;
· Rapid infiltration, hydrophilic stability;
· Lightweight, flexible, and with superior adhesion.
Scan the QR code on the poster to add our assistant and reserve your spot for the live broadcast!


Shen Chenye
White Coat Origin Biotech | Chief Operating Officer
Holds an Executive MBA from Cheung Kong Graduate School of Business and a Master’s degree in Applied Commerce from the University of Melbourne, Australia. Previously served in Audit and Corporate Advisory at KPMG, as Chief Financial Officer of Shanghai Quewo Information Technology Co., Ltd., as President of Shanghai Louran Information Technology Co., Ltd., and as Founding Partner of Xiangyou Capital.

Ma Li
Meiwei Dental Care Group | Director of Implantology
DCC Co-founder、Chinese Non-State Medical Institutions Association National Expert Pool for Stomatology Industry EvaluationExpert,Director, China Expert Committee of the International Congress of Implantologists (ICIO), Visiting Professor at the Medical School of Jingchu University of Technology,United StatesDentsply Sirona Certified Implant Instructor、SwitzerlandStraumann Group Invited Lecturer、Young Lecturer, Nobel Biocare Implantology (Sweden)、Certified Lecturer, Geistlich Biomaterials, Switzerland、C-Tech Certified Instructor, Italy、DaBo Medical - Invited Lecturer at the BIO-DBM Academy of Lianjie Biology.
About Baiyiyuan Bio
Shanghai Baiyiyuan Biological Engineering Co., Ltd., registered and established in November 2011 in Zhangjiang High-Tech Park, Pudong New Area, Shanghai, operates two GMP-compliant industrial bases in Pudong New Area, Shanghai, and Nantong, Jiangsu Province. With its marketing center located at Huaning International Plaza on Xuanhua Road, Changning District, Shanghai, the company is a high-tech enterprise integrating research and development, production, and sales.
The company boasts a first-class R&D team with a global perspective, as well as a professional and highly qualified medical services team. It is committed to providing society with advanced series of biological tissue regeneration materials and regenerative medical aesthetics products. With an independently owned intellectual property technology system, the company focuses on the independent research, development, and production of biomedical material products for tissue regeneration, wound repair, and regenerative medical aesthetics.
On the Debut of Artery's Select New Products
“Artery Select New Product Showcase” is a live-streaming program under the “Artery Select” brand, dedicated to supporting medical enterprises in launching innovative products. The program’s mission is to empower every milestone launch of innovative medical products.
Scan the QR code below to contact the assistant and schedule a live stream.
(If already added, please proactively contact the assistant.)
